CONMED Corporation
CNMD
$52.29
$1.142.23%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 110.20M | 118.75M | 132.42M | 131.74M | 98.59M |
Total Depreciation and Amortization | 71.40M | 70.67M | 70.46M | 70.15M | 70.05M |
Total Amortization of Deferred Charges | 7.12M | 7.14M | 7.10M | 7.46M | 7.56M |
Total Other Non-Cash Items | 15.93M | 10.32M | -3.29M | -19.16M | 8.30M |
Change in Net Operating Assets | -39.44M | -27.50M | -39.72M | -10.16M | -9.55M |
Cash from Operations | 165.21M | 179.38M | 166.97M | 180.03M | 174.95M |
Capital Expenditure | -16.97M | -14.83M | -13.08M | -13.90M | -15.87M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 850.00K | 850.00K | -- | 0.00 | 0.00 |
Cash from Investing | -16.12M | -13.98M | -13.08M | -13.90M | -15.87M |
Total Debt Issued | 659.67M | 663.00M | 751.00M | 781.00M | 819.00M |
Total Debt Repaid | -747.25M | -765.59M | -823.00M | -857.00M | -901.00M |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -24.71M | -24.68M | -24.65M | -24.62M | -24.61M |
Other Financing Activities | -32.53M | -35.12M | -54.35M | -58.07M | -50.49M |
Cash from Financing | -144.83M | -162.38M | -151.00M | -158.70M | -157.09M |
Foreign Exchange rate Adjustments | 800.00K | -1.39M | -2.72M | 535.00K | -960.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 5.07M | 1.63M | 163.00K | 7.97M | 1.02M |